Zeposia 0.92 MG capsule 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F1P34
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,609
Award facts
- Contract value 100% obligated
- $14,609.25 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order by the Defense Logistics Agency (DLA) for Zeposia 0.92 mg capsules (30-count units) with a ceiling value of $14,609.25. This non-competitive, firm fixed-price delivery order was awarded on December 12, 2025, with an ultimate completion date of January 6, 2026. The award represents a child order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which is valued at $999,999,999 and extends through December 2026.
AmerisourceBergen Drug Corp serves as a primary pharmaceutical distributor for federal medical procurement, with particular focus on supporting military and veteran healthcare systems through the DLA's Medical Supply Chain. Zeposia is an immunosuppressant medication used in the treatment of multiple sclerosis and ulcerative colitis, reflecting the company's role in supplying specialized therapeutic medications to support military healthcare programs. The delivery order will be fulfilled from the company's Conshohocken, Pennsylvania location. This award demonstrates AmerisourceBergen's continued capability to deliver pharmaceutical products through open competition and is consistent with the company's extensive portfolio of federal medical supply contracts across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26F1P34?
SPE2DR26F1P34 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 12, 2025.
How much is contract SPE2DR26F1P34 worth?
The government has obligated $14,609 on SPE2DR26F1P34.
Is contract SPE2DR26F1P34 an order under another contract?
Yes. SPE2DR26F1P34 is a delivery order under SPE2DR25D2205, an indefinite delivery contract.
Was contract SPE2DR26F1P34 competed?
The extent of competition for SPE2DR26F1P34 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award